U.S. and EU-5 Prefilled Syringe Small Molecule Market Will Reach a Valuation of US $17.1 Bn by the End of 2024
The U.S. and EU-5 prefilled syringe small molecule market is prognosticated in a report by Transparency Market Research (TMR) to find Sanofi, Mylan N.V., and Teva Pharmaceutical Industries Ltd. taking a leading position in terms of growth. The three companies secured a colossal share of the market in a recent year. Copaxone, a popular drug brand of Teva, helped the company to maintain its king's share for a pretty long period of time. With a view to gain a competitive...
View full press release